Biotechnology Transfer & Commercialization Conference
24 Oct 2012 - 26 Oct 2012 - Philadelphia, PA, USA
Leading innovations in biotech advancement and discovery are found within academic institutions and emerging companies. These organizations play an increasingly important role in developing new drug therapies for the treatment of diseases ranging from Alzheimer’s to cancer to cystic fibrosis to HIV/AIDS and many others. A gulf exists between early research and commercial drug development. The next steps in drug advancements are both challenging and expensive including advanced clinical trials up to the marketing of successful therapies, requiring significant investments. An era of biotech business paradigm shifts requires a new understanding among the various market segments.Bridging the gulf requires a dialogue among academic, investment and commercial organizations. GTC’s Biotechnology Transfer & Commercialization Conference will bring together the players needed to move the industry forward. Leading universities, pharmaceutical companies, venture capital, foundations and biotech companies will come together to share their perspectives, discuss new models of cooperation and develop the business relationships that get deals done. Together they will create new technologies, new companies and new medicines.